Brokerage Firm Rating Update on Patterson Companies (PDCO)

Patterson Companies (PDCO) : Zacks Investment Research ranks Patterson Companies (PDCO) as 4, which is a Sell recommendation. 2 research analysts consider that the stocks fundamentals point to a bright future, hence they rate the stock as a Strong Buy. Not everyone is convinced about the stocks future, hence, the stock receives 1 Sell recommendation. A total of 4 analysts believe that the stock has a limited upside, hence they advise a Hold. The average broker rating of 7 research analysts is 2.57, which indicates as a Hold.

Patterson Companies (PDCO) has been rated by 4 research analysts. Fundamentally, the highest shorterm price forecast for the stock is expected to reach $65 and the lowest price target forecast is $44. The average forecast of all the analysts is $52 and the expected standard deviation is $9.06.


Company shares have received an average consensus rating of Hold for the current week Also, Major Brokerage house, Baird maintains its ratings on Patterson Companies (NASDAQ:PDCO). In the latest research report, Baird lowers the target price from $51 per share to $49 per share. According to the latest information available, the shares are now rated Neutral by the analysts at the agency. The rating by the firm was issued on August 26, 2016.

Patterson Companies (NASDAQ:PDCO): The stock opened at $46.93 and touched an intraday high of $47.34 on Wednesday. During the day, the stock corrected to an intraday low of $46.805, however, the bulls stepped in and pushed the price higher to close in the green at $47.18 with a gain of 0.38% for the day. The total traded volume for the day was 840,897. The stock had closed at $47 in the previous trading session.

Patterson Companies, Inc. is a distributor serving the dental, veterinary and rehabilitation supply markets. The Company operates through three segments: dental supply, veterinary supply and rehabilitation supply. The Companys dental supply segment provides consumable products (including x-ray film, restorative materials, hand instruments and sterilization products); basic and advanced technology dental equipment; practice management and clinical software; patient education systems, and office forms and stationery. The Companys veterinary supply segment distributes veterinary supplies to companion-pet (dogs, cats and other common household pets), equine and large animal veterinarians and veterinary clinics, public and private institutions and shelters across the United States and in the United Kingdom. The rehabilitation supply segment distributes rehabilitation medical supplies and equipment.

Leave a Reply

Get Pre-Market Alerts!

Get Pre-Market Analysts' Upgrades, Downgrades, Earnings & Initiations with our FREE daily email newsletter.